CreditReports.dk
HomeScreen companies

MC2 Therapeutics A/S Financials, key figures and credit report

CVR number: 29526346 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Agern Alle 24-26, 2970 Hørsholm tel: 53514153
Gross profit 43 233.9 kDKK FY 2025 +14,598.7% vs 2024
EBIT 14 759.1 kDKK FY 2025 +143.9% vs 2024
Net debt 258 362.3 kDKK FY 2025 -1.9% vs 2024
Quick ratio 1.1 FY 2025 -1.3 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-4 727.29-74 371.73576.83- 298.1943 233.90
Employee benefit expenses-31 462.75-29 368.25-32 616.86-31 851.26-27 230.98
Other operating expenses-17.03
Total depreciation- 703.50-1 540.16-1 508.69-1 477.19-1 226.78
EBIT-36 893.54- 105 280.13-33 548.72-33 626.6414 759.12
Other financial income224.301 972.225 477.943 866.3913 816.77
Other financial expenses-3 102.65-8 295.99-19 726.37-30 650.88-36 360.51
Pre-tax profit-39 771.89- 111 603.90-47 797.15-60 411.13-7 784.62
Income taxes14 548.9310 189.175 928.257 388.7618.81
Net earnings-25 222.96- 101 414.73-41 868.90-53 022.37-7 765.81

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Buildings5 702.434 819.944 400.513 976.783 182.60
Machinery and equipment2 774.482 232.091 781.031 373.64950.95
Tangible assets total8 476.917 052.036 181.545 350.434 133.55
Investments total271.58271.58444.00455.10336.15
Long term receivables total
Finished products/goods5 354.6611 029.3213 935.7118 294.0222 075.76
Advance payments4 481.84
Inventories total5 354.6615 511.1613 935.7118 294.0222 075.76
Current trade debtors5 238.2214 471.797 691.6152 118.7036 729.32
Prepayments and accrued income899.1313 676.365 593.402 108.08232.83
Current other receivables9 595.024 919.531 795.721 644.433 935.85
Current deferred tax assets19 534.9019 133.146 003.1313 771.77
Short term receivables total35 267.2652 200.8321 083.8669 642.9940 897.99
Cash and bank deposits18 591.308 628.4915 997.0516 269.0118 906.36
Cash and cash equivalents18 591.308 628.4915 997.0516 269.0118 906.36
Balance sheet total (assets)67 961.7183 664.0857 642.16110 011.5486 349.82

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital6 611.486 611.486 611.486 611.486 611.48
Retained earnings-2 486.13-27 846.70- 129 276.44- 172 075.61- 223 324.60
Profit of the financial year-25 222.96- 101 414.73-41 868.90-53 022.37-7 765.81
Minority interest (BS)-83.48- 101.30- 116.74- 135.60
Shareholders equity total-21 097.61- 122 733.43- 164 635.15- 218 603.23- 224 614.52
Provisions3 000.59
Non-current advances received3 856.878 578.825 766.02
Non-current trade creditors17 430.50
Non-current owed to group member19 131.81156 317.29189 574.61270 718.61247 268.68
Non-current deferred tax liabilities914.03837.61873.92898.95936.67
Non-current liabilities total20 045.84178 442.27199 027.35271 617.57253 971.37
Current loans from credit institutions9 000.0030 000.00
Advances received503.074 425.3220 997.001 326.21
Current trade creditors42 393.7426 422.4917 317.7624 264.2221 986.36
Other non-interest bearing current liabilities26 619.741 029.671 506.892 735.98679.82
Current liabilities total69 013.4827 955.2323 249.9756 997.2053 992.39
Balance sheet total (liabilities)67 961.7183 664.0857 642.16110 011.5486 349.82
Page generated